Vestal Point Capital »

Genedx Holdings Corp shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Genedx Holdings Corp (WGS) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Genedx Holdings Corp

Tip: Access up to 7 years of quarterly data

All positions including Genedx Holdings Corp held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genedx Holdings Corp by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $16M 250k 64.22

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Genedx Holdings Corp

Corvex Management
Casdin Capital
BlackRock
Westfield Capital Management Company
Goldman Sachs Group
ARK Investment Management
Vanguard Group
Summit Partners Public Asset Management
Oracle Investment Management
Vanguard Capital Management
FMR
William Blair Investment Management
Citadel Advisors
Susquehanna International
Zweig-DiMenna Associates

View all funds holding Genedx Holdings Corp